These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27207629)

  • 21. Molecular modelling studies on Arylthioindoles as potent inhibitors of tubulin polymerization.
    Coluccia A; Sabbadin D; Brancale A
    Eur J Med Chem; 2011 Aug; 46(8):3519-25. PubMed ID: 21621885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and anticancer properties of IsoCombretaQuinolines as potent tubulin assembly inhibitors.
    Khelifi I; Naret T; Renko D; Hamze A; Bernadat G; Bignon J; Lenoir C; Dubois J; Brion JD; Provot O; Alami M
    Eur J Med Chem; 2017 Feb; 127():1025-1034. PubMed ID: 28166995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors.
    Sun B; Li L; Hu QW; Xie F; Zheng HB; Niu HM; Yuan HQ; Lou HX
    Eur J Med Chem; 2016 Oct; 121():484-499. PubMed ID: 27318123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel antitubulin agents by using a virtual screening approach based on a 7-point pharmacophore model of the tubulin colchi-site.
    Massarotti A; Theeramunkong S; Mesenzani O; Caldarelli A; Genazzani AA; Tron GC
    Chem Biol Drug Des; 2011 Dec; 78(6):913-22. PubMed ID: 22039890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitotic cell death induction by targeting the mitotic spindle with tubulin-inhibitory indole derivative molecules.
    Di Cesare E; Verrico A; Miele A; Giubettini M; Rovella P; Coluccia A; Famiglini V; La Regina G; Cundari E; Silvestri R; Lavia P
    Oncotarget; 2017 Mar; 8(12):19738-19759. PubMed ID: 28160569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine is an anti-inflammatory TLR-2, -4 and -5 response mediator in human monocytes.
    Wang H; Graves MW; Zhou H; Gu Z; Lamont RJ; Scott DA
    Inflamm Res; 2016 Jan; 65(1):61-9. PubMed ID: 26613980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open innovation for phenotypic drug discovery: The PD2 assay panel.
    Lee JA; Chu S; Willard FS; Cox KL; Sells Galvin RJ; Peery RB; Oliver SE; Oler J; Meredith TD; Heidler SA; Gough WH; Husain S; Palkowitz AD; Moxham CM
    J Biomol Screen; 2011 Jul; 16(6):588-602. PubMed ID: 21521801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrrolotetrazinones deazaanalogues of temozolomide induce apoptosis in Jurkat cell line: involvement of tubulin polymerization inhibition.
    Viola G; Cecconet L; Leszl A; Basso G; Brun P; Salvador A; Dall'Acqua F; Diana P; Barraja P; Cirrincione G
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1235-51. PubMed ID: 19363609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triazolopyridinyl-acrylonitrile derivatives as antimicrotubule agents: Synthesis, in vitro and in silico characterization of antiproliferative activity, inhibition of tubulin polymerization and binding thermodynamics.
    Briguglio I; Laurini E; Pirisi MA; Piras S; Corona P; Fermeglia M; Pricl S; Carta A
    Eur J Med Chem; 2017 Dec; 141():460-472. PubMed ID: 29055869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.
    Yin Y; Qiao F; Jiang LY; Wang SF; Sha S; Wu X; Lv PC; Zhu HL
    Bioorg Med Chem; 2014 Aug; 22(15):4285-92. PubMed ID: 24916028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ; Li YJ; Jiang AQ; Yang MR; Zhu QZ; Dong H; Zhu HL
    Eur J Med Chem; 2015 Apr; 94():447-57. PubMed ID: 25828827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Aldimine-Type Schiff Bases of 4-Amino-5-[(3,4,5-trimethoxyphenyl)methyl]-1,2,4-triazole-3-thione/thiol: Docking Study, Synthesis, Biological Evaluation, and Anti-Tubulin Activity.
    Ameri A; Khodarahmi G; Hassanzadeh F; Forootanfar H; Hakimelahi GH
    Arch Pharm (Weinheim); 2016 Aug; 349(8):662-81. PubMed ID: 27320785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New indole-based chalconoids as tubulin-targeting antiproliferative agents.
    Mirzaei H; Shokrzadeh M; Modanloo M; Ziar A; Riazi GH; Emami S
    Bioorg Chem; 2017 Dec; 75():86-98. PubMed ID: 28922629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis through tubulin inhibition in human cancer cells by new chromene-based chalcones.
    Aryapour H; Riazi GH; Ahmadian S; Foroumadi A; Mahdavi M; Emami S
    Pharm Biol; 2012 Dec; 50(12):1551-60. PubMed ID: 22984888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, anticancer activity and molecular docking studies on a series of heterocyclic trans-cyanocombretastatin analogues as antitubulin agents.
    Penthala NR; Zong H; Ketkar A; Madadi NR; Janganati V; Eoff RL; Guzman ML; Crooks PA
    Eur J Med Chem; 2015 Mar; 92():212-20. PubMed ID: 25557492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
    J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of novel 2-phenyl-imidazo[1,2-a]pyridine analogues targeting tubulin polymerization as antiproliferative agents.
    An W; Wang W; Yu T; Zhang Y; Miao Z; Meng T; Shen J
    Eur J Med Chem; 2016 Apr; 112():367-372. PubMed ID: 26927488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis of C
    Guggilapu SD; Lalita G; Reddy TS; Prajapti SK; Nagarsenkar A; Ramu S; Brahma UR; Lakshmi UJ; Vegi GMN; Bhargava SK; Babu BN
    Eur J Med Chem; 2017 Mar; 128():1-12. PubMed ID: 28131777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y; Lu X; Chen K; Yan R; Li QS; Zhu HL
    Bioorg Med Chem; 2012 Jan; 20(2):903-9. PubMed ID: 22192936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.